Last updated on May 2017

Type 2 Diabetes with Sulfonylureas

Brief description of study

Type 2 Diabetes with Sulfonylureas

Detailed Study Description

This study is a 2 year study that will evaluate the effectiveness and safety of the investigational medication, Sotagliflozin.

Dosing for this study involves 2 tablets of Sotagliflozin by mouth daily or 2 tablets of placebo, which has no therapeutic effect.

Clinical Study Identifier: TX149479

Contact Investigators or Research Sites near you

Start Over

Customer Service

Phoenix Medical Research
Peoria, AZ USA
  Connect »